1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of ANK mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANK mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ANK mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANK mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ANK mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ANK mRNA CTD PMID:15289156 17beta-estradiol multiple interactions ISO RGD:619925 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of ANKH mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO RGD:734405 6480464 EGF protein promotes the reaction [Estradiol results in increased expression of ANKH mRNA] CTD PMID:24758408 17beta-estradiol increases expression ISO RGD:734405 6480464 Estradiol results in increased expression of ANKH mRNA CTD PMID:21185374 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:734405 6480464 Dihydrotestosterone results in increased expression of ANKH mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANK mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:619925 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANKH mRNA CTD PMID:21215274 , PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ANK mRNA CTD PMID:21570461 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of ANK mRNA CTD PMID:20713471 2,6-dinitrotoluene affects expression ISO RGD:619925 6480464 2, 6-dinitrotoluene affects the expression of ANK mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:734405 6480464 Lactic Acid results in decreased expression of ANKH mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:619925 6480464 3 more ... CTD PMID:23196670 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of ANK mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol decreases methylation ISO RGD:734405 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of ANKH gene CTD PMID:31601247 7,12-dimethyltetraphene increases expression ISO RGD:619925 6480464 9 more ... CTD PMID:19480007 8-Br-cAMP increases expression ISO RGD:734405 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ANKH mRNA CTD PMID:20147733 acetamide decreases expression ISO RGD:619925 6480464 acetamide results in decreased expression of ANKH mRNA CTD PMID:31881176 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of ANK mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:734405 6480464 Aflatoxin B1 results in increased methylation of ANKH intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:734405 6480464 Aflatoxin B1 results in decreased methylation of ANKH gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:734405 6480464 Tretinoin results in increased expression of ANKH mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression ISO RGD:734405 6480464 Tretinoin results in decreased expression of ANKH mRNA CTD PMID:33167477 ammonium chloride affects expression ISO RGD:619925 6480464 Ammonium Chloride affects the expression of ANKH mRNA CTD PMID:16483693 amphetamine decreases expression ISO RGD:619925 6480464 Amphetamine results in decreased expression of ANKH mRNA CTD PMID:30779732 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ANK mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:734405 6480464 Arsenic affects the methylation of ANKH gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:734405 6480464 Arsenic affects the methylation of ANKH gene CTD PMID:25304211 benzene increases expression ISO RGD:734405 6480464 Benzene results in increased expression of ANKH mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:734405 6480464 Benzo(a)pyrene results in decreased expression of ANKH mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:734405 6480464 Benzo(a)pyrene affects the methylation of ANKH intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:734405 6480464 Benzo(a)pyrene results in decreased methylation of ANKH promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of ANK intron CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ANK mRNA CTD PMID:22228805 , PMID:23735875 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ANK mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:734405 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene increases methylation ISO RGD:734405 6480464 benzo(e)pyrene results in increased methylation of ANKH intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANK mRNA CTD PMID:26063408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANK mRNA CTD PMID:35479511 bisphenol A affects expression ISO RGD:619925 6480464 bisphenol A affects the expression of ANKH mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:619925 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of ANKH mRNA CTD PMID:26496021 buspirone decreases expression ISO RGD:619925 6480464 Buspirone results in decreased expression of ANKH mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:734405 6480464 butyraldehyde results in decreased expression of ANKH mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:734405 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ANKH mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:734405 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ANKH mRNA CTD PMID:35301059 calcitriol multiple interactions ISO RGD:734405 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ANKH mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:734405 6480464 Calcitriol results in increased expression of ANKH mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:734405 6480464 Carbamazepine affects the expression of ANKH mRNA CTD PMID:25979313 CGP 52608 multiple interactions ISO RGD:734405 6480464 CGP 52608 promotes the reaction [RORA protein binds to ANKH gene] CTD PMID:28238834 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of ANK mRNA CTD PMID:33711761 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ANK mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ANK mRNA] CTD PMID:17585979 copper atom multiple interactions ISO RGD:734405 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ANKH mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:734405 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ANKH mRNA CTD PMID:20971185 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of ANK mRNA CTD PMID:15289156 dorsomorphin multiple interactions ISO RGD:734405 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:734405 6480464 Doxorubicin results in increased expression of ANKH mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:734405 6480464 entinostat results in increased expression of ANKH mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:734405 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKH mRNA CTD PMID:27188386 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of ANK mRNA CTD PMID:30319688 fenthion decreases expression EXP 6480464 Fenthion results in decreased expression of ANK mRNA CTD PMID:34813904 flavonoids decreases expression ISO RGD:619925 6480464 Flavonoids results in decreased expression of ANKH mRNA CTD PMID:18035473 flutamide increases expression ISO RGD:619925 6480464 Flutamide results in increased expression of ANKH mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ANK mRNA CTD PMID:22206623 fulvestrant decreases methylation ISO RGD:734405 6480464 Fulvestrant results in decreased methylation of ANKH gene CTD PMID:31601247 genistein increases expression EXP 6480464 Genistein results in increased expression of ANK mRNA CTD PMID:15289156 irinotecan affects expression ISO RGD:619925 6480464 Irinotecan affects the expression of ANKH mRNA CTD PMID:20097248 leflunomide decreases expression ISO RGD:619925 6480464 leflunomide results in decreased expression of ANKH mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:734405 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ANKH mRNA CTD PMID:35811015 methapyrilene decreases expression ISO RGD:619925 6480464 Methapyrilene results in decreased expression of ANKH mRNA CTD PMID:30467583 methapyrilene increases methylation ISO RGD:734405 6480464 Methapyrilene results in increased methylation of ANKH intron CTD PMID:30157460 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of ANK mRNA CTD PMID:34813904 methotrexate increases expression ISO RGD:734405 6480464 Methotrexate results in increased expression of ANKH mRNA CTD PMID:17400583 nefazodone decreases expression ISO RGD:619925 6480464 nefazodone results in decreased expression of ANKH mRNA CTD PMID:24136188 nickel sulfate increases expression ISO RGD:734405 6480464 nickel sulfate results in increased expression of ANKH mRNA CTD PMID:22714537 nimesulide decreases expression ISO RGD:619925 6480464 nimesulide results in decreased expression of ANKH mRNA CTD PMID:24136188 oxaliplatin multiple interactions ISO RGD:619925 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ANKH mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO RGD:619925 6480464 oxaliplatin results in decreased expression of ANKH mRNA CTD PMID:25729387 panobinostat multiple interactions ISO RGD:734405 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKH mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:734405 6480464 panobinostat results in increased expression of ANKH mRNA CTD PMID:26272509 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ANK mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ANK mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:619925 6480464 Acetaminophen results in increased expression of ANKH mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:734405 6480464 Acetaminophen results in increased expression of ANKH mRNA CTD PMID:22230336 paracetamol decreases expression ISO RGD:734405 6480464 Acetaminophen results in decreased expression of ANKH mRNA CTD PMID:21420995 , PMID:26690555 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ANK mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ANK mRNA CTD PMID:36331819 phenformin decreases expression ISO RGD:619925 6480464 Phenformin results in decreased expression of ANKH mRNA CTD PMID:31324951 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ANK mRNA CTD PMID:19710929 progesterone affects expression EXP 6480464 Progesterone affects the expression of ANK mRNA CTD PMID:17251523 propanal decreases expression ISO RGD:734405 6480464 propionaldehyde results in decreased expression of ANKH mRNA CTD PMID:26079696 quercetin increases expression ISO RGD:619925 6480464 Quercetin results in increased expression of ANKH mRNA CTD PMID:18095365 quercetin increases expression ISO RGD:734405 6480464 Quercetin results in increased expression of ANKH mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:734405 6480464 Lactic Acid results in decreased expression of ANKH mRNA CTD PMID:30851411 rotenone decreases expression ISO RGD:619925 6480464 Rotenone results in decreased expression of ANKH mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:734405 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ANKH mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:734405 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:734405 6480464 Silicon Dioxide analog results in decreased expression of ANKH mRNA CTD PMID:25895662 sulforaphane decreases expression ISO RGD:734405 6480464 sulforaphane results in decreased expression of ANKH mRNA CTD PMID:31838189 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of ANK mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:734405 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ANKH mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:734405 6480464 Testosterone results in increased expression of ANKH mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ANK mRNA CTD PMID:31919559 thapsigargin decreases expression ISO RGD:619925 6480464 Thapsigargin results in decreased expression of ANKH protein CTD PMID:35544339 thioacetamide decreases expression ISO RGD:619925 6480464 Thioacetamide results in decreased expression of ANKH mRNA CTD PMID:34492290 topotecan multiple interactions ISO RGD:619925 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ANKH mRNA CTD PMID:25729387 topotecan decreases expression ISO RGD:619925 6480464 Topotecan results in decreased expression of ANKH mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:619925 6480464 Trichloroethylene results in increased expression of ANKH mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:734405 6480464 trichostatin A results in increased expression of ANKH mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:734405 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKH mRNA CTD PMID:27188386 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ANK mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:734405 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKH mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:734405 6480464 Valproic Acid results in increased expression of ANKH mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:734405 6480464 Valproic Acid results in decreased methylation of ANKH gene CTD PMID:29154799 valproic acid affects expression ISO RGD:734405 6480464 Valproic Acid affects the expression of ANKH mRNA CTD PMID:25979313 vinclozolin increases expression ISO RGD:619925 6480464 vinclozolin results in increased expression of ANKH mRNA CTD PMID:22570695 vinclozolin increases methylation ISO RGD:619925 6480464 vinclozolin results in increased methylation of ANKH gene CTD PMID:31079544 vorinostat decreases expression ISO RGD:734405 6480464 vorinostat results in decreased expression of ANKH mRNA CTD PMID:27188386